Asterias Biotherapeutics to Report Second Quarter Results on August 15, 2016
FREMONT, Calif., Aug. 1, 2016 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company with three clinical-stage development programs focused on the emerging field of regenerative medicine, today announced that it will release second quarter financial...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]-august-15-2016-300306526.html
